Register information Patent

DE file number : 60 2010 044 588.7 (Status: pending/in force, Query started: May 13, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2010 044 588.7
96EP file numberEAKZ10 70 4298.8
86WO file numberWAKZPCT/US2010/024127
97EP publication numberEPN2395979
87WO publication numberWPN2010093944
54Designation/titleTIAMORPHES CDDO-ME ENTHALTENDE ORALE DOSIERZUSAMMENSETZUNGEN MIT VERZÖGERTER FREISETZUNG
51IPC main classICM
(ICMV)		 A61K 9/16 (2006.01)
22DE application dateDATFeb 12, 2010
96EP application dateEATFeb 12, 2010
86WO application dateWATFeb 12, 2010
43Date of first publicationOTAug 19, 2010
Date of publication of grantPETAug 23, 2017
71/73Applicant/ownerINHReata Pharmaceuticals Holdings, LLC, Plano, TX, US
72InventorINZHANG, Jiang, CoppellTexas 75019, US; MEYER, Colin J., FriscoTexas 75034, US
74RepresentativeVTRStolmár & Partner Patentanwälte PartG mbB, 80331 München, DE
Address for service Stolmár & Partner Patentanwälte, 80331 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
152608 P
Feb 13, 2009
Due dateFT
FG		Feb 28, 2026
Annual fee for the 17th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002395979
Searchable text: EP000002395979
Original document: EP000002395979B1
Searchable text: EP000002395979B1
Original document: WO002010093944
Searchable text: WO002010093944
43Date of first publicationEVTAug 19, 2010
Date of the first transfer into DPMAregisterEREGTFeb 3, 2012
Date of the (most recent) update in DPMAregisterREGTJan 29, 2025
(Show all update days)(Hide all update days)
  • Jan 29, 2025
    • Due date: changed
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 19.08.2010: deleted
  • Apr 25, 2024; Mar 16, 2024; Jan 19, 2024; Jan 24, 2023; Jan 22, 2022; Feb 3, 2021; Jan 24, 2020; Aug 13, 2019; Mar 8, 2019; Jan 23, 2019; Aug 23, 2018; Jul 19, 2018; Jan 27, 2018; Dec 7, 2017; Sep 28, 2017; Aug 24, 2017; Aug 17, 2017; Apr 6, 2017; Feb 16, 2013
    • Historical data not available for this/these date(s)
  • Feb 3, 2012
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Aug 19, 2010  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Dec 21, 2011  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Feb 2, 2012 Feb 2, 2012 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Aug 23, 2017  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Sep 28, 2017 Sep 28, 2017 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision May 24, 2018 Aug 23, 2018 Details anzeigen
7 New applicant/owner details New applicant/owner details Mar 15, 2024 Apr 25, 2024 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTAug 19, 2010
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTDec 21, 2011
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTFeb 2, 2012
Issue numberHN5
YearPJ2012
Publication dateVTFeb 2, 2012
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTAug 23, 2017
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTSep 28, 2017
Issue numberHN39
YearPJ2017
Publication dateVTSep 28, 2017
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMay 24, 2018
Issue numberHN34
YearPJ2018
Publication dateVTAug 23, 2018
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTMar 15, 2024
Issue numberHN17
YearPJ2024
Publication dateVTApr 25, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHReata Pharmaceuticals Holdings, LLC, Plano, TX, US
71/73Previous applicant/ownerINHFReata Pharmaceuticals, Inc., Irving, Tex., US
Date of update of the procedureREGTApr 25, 2024